In vivo experiments confirmed that LTβR expression affects tumor growth in WT mice, and LTβR knockout tumors exhibited enhanced sensitivity to nutlin-3a, a drug that inhibits MDM2-mediated p53 degradation. The gene discussed is LTBR; the disease is neoplasm.